| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $474.4M | +16.2% |
| R&D Expense | $72.9M | -4.5% |
| SG&A Expense | $111.6M | +40.1% |
| Operating Income | $17.1M | +12.8% |
| Interest Expense | $12.2M | +35.2% |
| Pre-tax Income | $4.9M | -62.9% |
| Income Tax | -$2.4M | -4.1% |
| Net Income | $7.2M | -52.9% |
| EPS (Basic) | $0.05 | -50.0% |
| EPS (Diluted) | $0.04 | -60.0% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $124.8M | +43.6% |
| Accounts Receivable | $74.6M | +9.9% |
| Current Assets | $264.9M | +19.8% |
| Total Assets | $1.19B | +2.0% |
| Current Liabilities | $82.5M | +21.7% |
| Long-term Debt | $155.0M | -31.1% |
| Total Liabilities | $282.3M | -21.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $131.6M | +81.6% |
| Capital Expenditures | $2.0M | -2.0% |
| Investing Cash Flow | -$34.7M | -89.8% |
| Financing Cash Flow | -$58.9M | -57.1% |
| Free Cash Flow | $129.6M | +84.0% |
| Stockholders' Equity |
| $909.5M |
| +12.5% |